{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T15:15:54Z","timestamp":1786634154543,"version":"build-2736575974"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,6,17]],"date-time":"2023-06-17T00:00:00Z","timestamp":1686960000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,6,17]],"date-time":"2023-06-17T00:00:00Z","timestamp":1686960000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Transl Psychiatry"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Functional movement disorders (FMD) are characterized by the presence of neurological symptoms that cannot be explained by typical neurological diseases or other medical conditions. First evidence showed that, compared to healthy controls (CTR), FMD patients presented increased levels of glutamate+glutamine in the anterior cingulate cortex\/medial prefrontal cortex, and decreased levels of glutamate in the cerebrospinal fluid, suggesting that a glutamatergic dysfunction might play a role in FMD pathophysiology. In this study, 12 FMD patients and 20 CTR were recruited and underwent venous blood sampling and urine collection: levels of glutamate, BDNF, dopamine, oxidative stress, creatinine, neopterin, and uric acid were analyzed. Participants also underwent a psychometric assessment investigating depression, anxiety, and alexithymia. We found that levels of glutamate, BDNF, and dopamine were significantly lower in the blood of FMD patients than CTR. Glutamate and dopamine levels were positively associated with levels of alexithymia. Our findings give further evidence that glutamatergic dysfunction might be involved in the pathophysiology of FMD, possibly representing a biomarker of disease; moreover, since glutamatergic and dopaminergic systems are closely interconnected, our results might have a relevance in terms of treatment options for FMD patients.<\/jats:p>","DOI":"10.1038\/s41398-023-02500-8","type":"journal-article","created":{"date-parts":[[2023,6,17]],"date-time":"2023-06-17T07:01:39Z","timestamp":1686985299000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Glutamatergic dysfunction, neuroplasticity, and redox status in the peripheral blood of patients with motor conversion disorders (functional movement disorders): a first step towards potential biomarkers discovery"],"prefix":"10.1038","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4426-6014","authenticated-orcid":false,"given":"Benedetta","family":"Demartini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronica","family":"Nistic\u00f2","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Benayoun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Chiara","family":"Cigognini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Ferrucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Vezzoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cinzia","family":"Dellanoce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Orsola","family":"Gambini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Priori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Mrakic-Sposta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,6,17]]},"reference":[{"key":"2500_CR1","doi-asserted-by":"crossref","unstructured":"American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 5th ed. Washington, DC: American Psychiatric Publishing; 2013.","DOI":"10.1176\/appi.books.9780890425596"},{"key":"2500_CR2","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/B978-0-12-801772-2.00005-9","volume":"139","author":"A Carson","year":"2016","unstructured":"Carson A, Lehn A. Epidemiology. Handb Clin Neurol. 2016;139:47\u201360.","journal-title":"Handb Clin Neurol"},{"key":"2500_CR3","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1136\/jnnp-2013-305321","volume":"85","author":"J Gelauff","year":"2014","unstructured":"Gelauff J, Stone J, Edwards M, Carson A. The prognosis of functional (psychogenic) motor symptoms: a systematic review. J Neurol Neurosurg Psychiatry. 2014;85:220\u20136.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2500_CR4","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.neubiorev.2020.10.019","volume":"120","author":"B Demartini","year":"2021","unstructured":"Demartini B, Nistic\u00f2 V, Edwards MJ, Gambini O, Priori A. The pathophysiology of functional movement disorders. Neurosci Biobehav Rev. 2021;120:387\u2013400. https:\/\/doi.org\/10.1016\/j.neubiorev.2020.10.019","journal-title":"Neurosci Biobehav Rev"},{"key":"2500_CR5","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1136\/jnnp-2020-323141","volume":"91","author":"BLC Thomsen","year":"2020","unstructured":"Thomsen BLC, Teodoro T, Edwards MJ. Biomarkers in functional movement disorders: a systematic review. J Neurol Neurosurg Psychiatry. 2020;91:1261\u20139. https:\/\/doi.org\/10.1136\/jnnp-2020-323141","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2500_CR6","doi-asserted-by":"publisher","first-page":"101798","DOI":"10.1016\/j.nicl.2019.101798","volume":"22","author":"I B\u00e8gue","year":"2019","unstructured":"B\u00e8gue I, Adams C, Stone J, Perez DL. Structural alterations in functional neurological disorder and related conditions: a software and hardware problem? Neuroimage Clin. 2019;22:101798 https:\/\/doi.org\/10.1016\/j.nicl.2019.101798","journal-title":"Neuroimage Clin"},{"key":"2500_CR7","doi-asserted-by":"publisher","first-page":"e52","DOI":"10.1212\/WNL.0000000000007717","volume":"93","author":"B Demartini","year":"2019","unstructured":"Demartini B, Gambini O, Uggetti C, Cariati M, Cadioli M, Goeta D, et al. Limbic neurochemical changes in patients with functional motor symptoms. Neurology. 2019;93:e52\u201358.","journal-title":"Neurology"},{"key":"2500_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41531-020-00140-z","volume":"6","author":"B Demartini","year":"2020","unstructured":"Demartini B, Invernizzi RW, Campiglio L, Bocci T, D\u2019Arrigo A, Arighi A, et al. Cerebrospinal fluid glutamate changes in functional movement disorders. Npj Parkinsons Dis. 2020;6:1\u20134.","journal-title":"Npj Parkinsons Dis"},{"key":"2500_CR9","doi-asserted-by":"publisher","first-page":"526","DOI":"10.4306\/pi.2016.13.5.526","volume":"13","author":"NI Kang","year":"2016","unstructured":"Kang NI, Park JI, Kim YK, Yang JC. Decreased plasma BDNF levels of patients with somatization disorder. Psychiatry Investig. 2016;13:526 https:\/\/doi.org\/10.4306\/pi.2016.13.5.526","journal-title":"Psychiatry Investig"},{"key":"2500_CR10","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1111\/j.1440-1819.2007.01710.x","volume":"61","author":"A Deveci","year":"2007","unstructured":"Deveci A, Aydemir O, Taskin O, Taneli F, Esen-Danaci AY. Serum brain\u2010derived neurotrophic factor levels in conversion disorder: comparative study with depression. Psychiatry Clin Neurosci. 2007;61:571\u20133.","journal-title":"Psychiatry Clin Neurosci"},{"key":"2500_CR11","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1017\/S1461145707008401","volume":"11","author":"F Ng","year":"2008","unstructured":"Ng F, Berk M, Dean O, Bush AI. Oxidative stress in psychiatric disorders: evidence base and therapeutic implications. Int J. Neuropsychopharmacol. 2008;11:851\u201376. https:\/\/doi.org\/10.1017\/S1461145707008401","journal-title":"Int J. Neuropsychopharmacol"},{"key":"2500_CR12","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1164\/ajrccm.160.1.9809140","volume":"160","author":"P Montuschi","year":"1999","unstructured":"Montuschi P, Corradi M, Ciabattoni G, Nightingale J, Kharitonov SA, Barnes PJ. Increased 8-isoprostane, a marker of oxidative stress, in exhaled condensate of asthma patients. Am J Respir Crit Care Med. 1999;160:216\u201320.","journal-title":"Am J Respir Crit Care Med"},{"key":"2500_CR13","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.freeradbiomed.2019.05.035","volume":"140","author":"K Ulrich","year":"2019","unstructured":"Ulrich K, Jakob U. The role of thiols in antioxidant systems. Free Radic Biol Med. 2019;140:14\u201327.","journal-title":"Free Radic Biol Med."},{"key":"2500_CR14","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1093\/ijnp\/pyx056","volume":"20","author":"P Belujon","year":"2017","unstructured":"Belujon P, Grace AA. Dopamine system dysregulation in major depressive disorders. Int J Neuropsychopharmacol. 2017;20:1036\u201346.","journal-title":"Int J Neuropsychopharmacol"},{"key":"2500_CR15","first-page":"1183","volume":"19","author":"F Niklasson","year":"1984","unstructured":"Niklasson F, Agren H. Brain energy metabolism and blood-brain barrier permeability in depressive patients: analyses of creatine, creatinine, urate, and albumin in CSF and blood. Biol Psychiatry. 1984;19:1183\u2013206.","journal-title":"Biol Psychiatry"},{"key":"2500_CR16","doi-asserted-by":"publisher","first-page":"125","DOI":"10.17116\/jnevro2020120101125","volume":"120","author":"YE Shilov","year":"2000","unstructured":"Shilov YE, Miroshnichenko II. Neopterin as a potential biomarker in neuropsychiatry. Zh Nevrol Psikhiatr Im S S Korsakova. 2000;120:125\u20139.","journal-title":"Zh Nevrol Psikhiatr Im S S Korsakova"},{"key":"2500_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12888-020-02891-8","volume":"20","author":"JX Chen","year":"2020","unstructured":"Chen JX, Feng JH, Zhang LG, Liu Y, Yang FD, Wang SL, et al. Association of serum uric acid levels with suicide risk in female patients with major depressive disorder: a comparative cross-sectional study. BMC Psychiatry. 2020;20:1\u20138.","journal-title":"BMC Psychiatry"},{"key":"2500_CR18","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1097\/WCO.0b013e32832dc169","volume":"22","author":"A Gupta","year":"2009","unstructured":"Gupta A, Lang AE. Psychogenic movement disorders. Curr Opin Neurol. 2009;22:430\u20136. https:\/\/doi.org\/10.1097\/WCO.0b013e32832dc169","journal-title":"Curr Opin Neurol"},{"key":"2500_CR19","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1001\/jamaneurol.2018.1264","volume":"75","author":"AJ Espay","year":"2018","unstructured":"Espay AJ, Aybek S, Carson A, Edwards MJ, Goldstein LH, Hallett M, et al. Current concepts in diagnosis and treatment of functional neurological disorders. JAMA Neurol. 2018;75:1132\u201341. https:\/\/doi.org\/10.1001\/jamaneurol.2018.1264","journal-title":"JAMA Neurol"},{"key":"2500_CR20","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1037\/0022-006x.56.6.893","volume":"56","author":"AT Beck","year":"1988","unstructured":"Beck AT, Epstein N, Brown G, Steer RA. An inventory for measuring clinical anxiety: psychometric properties. J Consult Clin Psychol. 1988;56:893\u20137. https:\/\/doi.org\/10.1037\/0022-006x.56.6.893","journal-title":"J Consult Clin Psychol"},{"key":"2500_CR21","volume-title":"Manual for the Beck Depression Inventory-II","author":"AT Beck","year":"1996","unstructured":"Beck AT, Steer RA, Brown GK. Manual for the Beck Depression Inventory-II. San Antonio, TX: Psychological Corporation; 1996."},{"key":"2500_CR22","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/0022-3999(94)90005-1","volume":"38","author":"RM Bagby","year":"1994","unstructured":"Bagby RM, Parker JDA, Taylor GJ. The twenty-item Toronto Alexithymia Scale-I.Item selection and cross-validation of the factor structure. J Psychosom Res. 1994;38:23\u201332.","journal-title":"J Psychosom Res"},{"key":"2500_CR23","doi-asserted-by":"publisher","first-page":"306179.","DOI":"10.1155\/2014\/306179","volume":"2014","author":"S Mrakic-Sposta","year":"2014","unstructured":"Mrakic-Sposta S, Gussoni M, Montorsi M, Porcelli S, Vezzoli A. A quantitative method to monitor reactive oxygen species production by electron paramagnetic resonance in physiological and pathological conditions. Oxid Med Cell Longev. 2014;2014:306179.","journal-title":"Oxid Med Cell Longev"},{"key":"2500_CR24","doi-asserted-by":"publisher","first-page":"32426","DOI":"10.1038\/srep32426","volume":"6","author":"G Strapazzon","year":"2016","unstructured":"Strapazzon G, Malacrida S, Vezzoli A, Dal Cappello T, Falla M, Lochner P, et al. Oxidative stress response to acute hypobaric hypoxia and its association with indirect measurement of increased intracranial pressure: a field study. Sci Rep. 2016;6:32426. https:\/\/doi.org\/10.1038\/srep32426","journal-title":"Sci Rep."},{"key":"2500_CR25","doi-asserted-by":"publisher","first-page":"157.","DOI":"10.1038\/s41424-018-0031-6","volume":"9","author":"S Moretti","year":"2018","unstructured":"Moretti S, Mrakic-Sposta S, Roncoroni L, Vezzoli A, Dellanoce C, Monguzzi E, et al. Oxidative stress as a biomarker for monitoring treated celiac disease. Clin Transl Gastroenterol. 2018;9:157.","journal-title":"Clin Transl Gastroenterol"},{"key":"2500_CR26","doi-asserted-by":"publisher","first-page":"1767265.","DOI":"10.1155\/2018\/1767265","volume":"2018","author":"S Mrakic-Sposta","year":"2018","unstructured":"Mrakic-Sposta S, Vezzoli A, Maderna L, Gregorini F, Montorsi M, Moretti S, et al. R (+)-Thioctic acid effects on oxidative stress and peripheral neuropathy in type II diabetic patients: preliminary results by electron paramagnetic resonance and electroneurography. Oxid Med Cell Longev. 2018;2018:1767265.","journal-title":"Oxid Med Cell Longev"},{"key":"2500_CR27","doi-asserted-by":"publisher","first-page":"282","DOI":"10.3389\/fnagi.2018.00282","volume":"10","author":"S Mrakic-Sposta","year":"2018","unstructured":"Mrakic-Sposta S, Di Santo SG, Franchini F, Arlati S, Zangiacomi A, Greci L, et al. Effects of combined physical and cognitive virtual reality-based training on cognitive impairment and oxidative stress in MCI patients: a pilot study. Front Aging Neurosci. 2018;10:282.","journal-title":"Front Aging Neurosci"},{"key":"2500_CR28","doi-asserted-by":"publisher","first-page":"836","DOI":"10.3390\/antiox10060836","volume":"10","author":"S Mrakic-Sposta","year":"2021","unstructured":"Mrakic-Sposta S, Gussoni M, Montorsi M, Vezzoli A. Comment on Menzel et al. 2021 Common and novel markers for measuring inflammation and oxidative stress ex vivo in research and clinical practice\u2014which to use regarding disease outcomes? Antioxidants 10:414. Antioxidants. 2021;10:836.","journal-title":"Antioxidants"},{"key":"2500_CR29","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1089\/ars.2017.7396","volume":"28","author":"SI Dikalov","year":"2018","unstructured":"Dikalov SI, Polienko YF, Kirilyuk I. Electron paramagnetic resonance measurements of reactive oxygen species by cyclic hydroxylamine spin probes. Antioxid Redox Signal. 2018;28:1433\u201343.","journal-title":"Antioxid Redox Signal"},{"key":"2500_CR30","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/0003-2697(82)90118-X","volume":"126","author":"LC Green","year":"1982","unstructured":"Green LC, Wagner DA, Glogowski J, Skipper PL, Wishnok JS, Tannenbaum SR. Analysis of nitrate, nitrite, and [15 N] nitrate in biological fluids. Anal Biochem. 1982;126:131\u20138.","journal-title":"Anal Biochem"},{"key":"2500_CR31","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1002\/bmc.3056","volume":"28","author":"C Dellanoce","year":"2014","unstructured":"Dellanoce C, Cozzi L, Zuddas S, Pratali L, Accinni R. Determination of different forms of aminothiols in red blood cells without washing erythrocytes. Biomed. Chromatogr. 2014;28:327\u201331.","journal-title":"Biomed. Chromatogr."},{"key":"2500_CR32","doi-asserted-by":"publisher","first-page":"6439037.","DOI":"10.1155\/2016\/6439037","volume":"2016","author":"A Vezzoli","year":"2016","unstructured":"Vezzoli A, Dellanoce C, Mrakic-Sposta S, Montorsi M, Moretti S, Tonini A, et al. Oxidative stress assessment in response to ultraendurance exercise: thiols redox status and ROS production according to duration of a competitive race. Oxid Med Cell Longev. 2016;2016:6439037.","journal-title":"Oxid Med Cell Longev"},{"key":"2500_CR33","doi-asserted-by":"publisher","first-page":"e0141780","DOI":"10.1371\/journal.pone.0141780","volume":"10","author":"S Mrakic-Sposta","year":"2015","unstructured":"Mrakic-Sposta S, Gussoni M, Moretti S, Pratali L, Giardini G, Tacchini P, et al. Effects of mountain ultra-marathon running on ROS production and oxidative damage by micro-invasive analytic techniques. PLoS ONE. 2015;10:e0141780.","journal-title":"PLoS ONE"},{"key":"2500_CR34","doi-asserted-by":"publisher","first-page":"110567","DOI":"10.1016\/j.mehy.2021.110567","volume":"150","author":"T Komagamine","year":"2021","unstructured":"Komagamine T, Kokubun N, Hirata K. Hystero-epilepsy in the tuesday lessons and NMDA receptor function: a hypothesis for dissociative disorder. Med Hypotheses. 2021;150:110567.","journal-title":"Med Hypotheses"},{"key":"2500_CR35","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1017\/S1092852900010427","volume":"10","author":"BM Cortese","year":"2005","unstructured":"Cortese BM, Phan KL. The role of glutamate in anxiety and related disorders. CNS Spectr. 2005;10:820\u201330.","journal-title":"CNS Spectr"},{"key":"2500_CR36","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1212\/WNL.0b013e3181f612bb","volume":"75","author":"WC LaFrance","year":"2010","unstructured":"LaFrance WC, Leaver K, Stopa EG, Papandonatos GD, Blum AS. Decreased serum BDNF levels in patients with epileptic and psychogenic nonepileptic seizures. Neurology. 2010;75:1285\u201391.","journal-title":"Neurology"},{"key":"2500_CR37","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1176\/appi.ajp.2013.13030392","volume":"170","author":"JW Murrough","year":"2013","unstructured":"Murrough JW, Iosifescu DV, Chang LC, Al Jurdi RK, Green CE, Perez AM, et al. Antidepressant efficacy of ketamine in treatment-resistant major depression: a two-site randomized controlled trial. Am J Psychiatry. 2013;170:1134\u201342.","journal-title":"Am J Psychiatry"},{"key":"2500_CR38","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.biopsych.2012.06.022","volume":"74","author":"JW Murrough","year":"2013","unstructured":"Murrough JW, Perez AM, Pillemer S, Stern J, Parides MK, aan het Rot M, et al. Rapid and longer-term antidepressant effects of repeated ketamine infusions in treatment-resistant major depression. Biol Psychiatry. 2013;74:250\u20136.","journal-title":"Biol Psychiatry"},{"key":"2500_CR39","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.neuropharm.2015.07.028","volume":"100","author":"OH Miller","year":"2016","unstructured":"Miller OH, Moran JT, Hall BJ. Two cellular hypotheses explaining the initiation of ketamine\u2019s antidepressant actions: direct inhibition and disinhibition. Neuropharmacology. 2016;100:17\u201326.","journal-title":"Neuropharmacology"},{"key":"2500_CR40","doi-asserted-by":"publisher","first-page":"11","DOI":"10.2174\/1570159X14666160309114549","volume":"15","author":"SE Wohleb","year":"2017","unstructured":"Wohleb SE, Gerhard D, Thomas A, Duman SR. Molecular and cellular mechanisms of rapid-acting antidepressants ketamine and scopolamine. Curr Neuropharmacol. 2017;15:11\u201320.","journal-title":"Curr Neuropharmacol"},{"key":"2500_CR41","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1016\/j.biopsych.2014.04.014.","volume":"76","author":"P Belujon","year":"2014","unstructured":"Belujon P, Grace AA. Restoring mood balance in depression: ketamine reverses deficit in dopamine-dependent synaptic plasticity. Biol Psychiatry. 2014;76:927\u201336. https:\/\/doi.org\/10.1016\/j.biopsych.2014.04.014.","journal-title":"Biol Psychiatry"}],"container-title":["Translational Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41398-023-02500-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41398-023-02500-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41398-023-02500-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,17]],"date-time":"2023-06-17T07:01:43Z","timestamp":1686985303000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41398-023-02500-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,17]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["2500"],"URL":"https:\/\/doi.org\/10.1038\/s41398-023-02500-8","relation":{},"ISSN":["2158-3188"],"issn-type":[{"value":"2158-3188","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,17]]},"assertion":[{"value":"8 November 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"212"}}